Инструмент | Доходность к погашению % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|---|---|---|---|---|---|---|---|---|
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7,59% | 150 K | 77,52% | 4,63% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7,40% | 15 K | 79,63% | 4,85% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AA5QDALLERGAN FNDG 15/25 | 7,32% | 0 | 99,18% | 3,80% | 2025-03-15 | 130,22 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,28% | 10 K | 79,20% | 4,75% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6,59% | 40 K | 87,51% | 4,55% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
6,00% | 50 K | 89,00% | 3,20% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,86% | 24,39 M | 83,68% | 4,25% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,77% | 0 | 87,32% | 4,45% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,67% | 0 | 90,79% | 4,70% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,66% | 7,39 M | 88,79% | 4,40% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,66% | 196 K | 92,07% | 4,88% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,65% | 1,5 M | 90,88% | 4,63% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,62% | 9,26 M | 98,59% | 5,50% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,60% | 554 K | 91,94% | 4,75% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,57% | 6,19 M | 93,24% | 4,85% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,51% | 55,41 M | 98,76% | 5,40% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,37% | 968 K | 99,81% | 5,35% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,36% | 7,12 M | 89,11% | 4,05% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,32% | 0 | 92,76% | 4,30% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,24% | 0 | 95,02% | 4,50% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,18% | 412 K | 95,78% | 4,55% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,08% | 0 | 99,42% | 3,60% | 2025-05-14 | 3,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,02% | 8,7 M | 100,16% | 5,05% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,00% | 4,78 M | 99,71% | 3,80% | 2025-03-15 | 2,89 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,91% | 18,86 M | 93,20% | 3,20% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,81% | 10,18 M | 100,66% | 4,95% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,68% | 8,77 M | 100,44% | 4,80% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,59% | 7,01 M | 98,87% | 4,25% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,57% | 0 | 98,20% | 3,20% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,54% | 31,16 M | 97,18% | 2,95% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,52% | 3,32 M | 100,57% | 4,80% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,10% | 0 | 95,03% | 2,63% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
XXS162262122ALLERGAN FNDG 17/29 | 4,01% | 0 | 92,88% | 2,13% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
3,86% | 0 | 96,53% | 2,95% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,01% | 0 | 102,15% | 3,80% | 2025-03-15 | 1,27 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,92% | 0 | 90,40% | 1,25% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,90% | 0 | 121,31% | 4,25% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,88% | 0 | 126,76% | 4,75% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,83% | 0 | 128,71% | 4,85% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,76% | 0 | 97,75% | 2,13% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,67% | 0 | 99,83% | 2,63% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,67% | 0 | 97,84% | 2,13% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,59% | 0 | 95,02% | 0,75% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,35% | 0 | 123,74% | 4,55% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
— | — | — | 3,80% | 2025-03-15 | — | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
— | — | — | 4,40% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |